Portfolio comparison
Novartis AG vs OLogN Technologies AG
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Top Patents2 enriched
US 10472419· 2019
How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint
US 7740842· 2010
How to Keep High-Concentration Antibody Medicines Stable in Liquid Form
Activity by Decade
2010s2
Company B
OLogN Technologies AG
Patents indexed
1
Year range
2017
Most recent
2017
consumer_electronicstelecommunicationsfinance
Top Patents1 enriched
US 9699159· 2017
How Wearable Devices Act as Secure Bridges for Transactions
Activity by Decade
2010s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.